SkinHealth Systems Inc.
SKIN · XNASCIK 1818093fmd_0E4806FN0CC645D6FH57PVWPGSManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 28 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Total revenues | 167 | 119 | 260 | 366 | 398 | 334 | 301 |
| Cost of revenue | 60 | 52 | 82 | 117 | 243 | 152 | 104 |
| Gross profit | 107 | 67 | 179 | 249 | 155 | 182 | 196 |
| Research and development | 5 | 3 | 8 | 8 | 10 | 6 | 6 |
| Selling, general and administrative | 88 | 81 | 210 | 266 | 276 | 244 | 212 |
| Total operating expenses | 93 | 84 | 218 | 275 | 286 | 250 | 217 |
| Operating income | 13 | (17) | (40) | (26) | (131) | (68) | (21) |
| Interest expense | – | – | 12 | 13 | 14 | 10 | 19 |
| Interest and investment income | – | – | 0 | 9 | 23 | 17 | 9 |
| Other non-operating income (expense) | (16) | (21) | (341) | (2) | 5 | 34 | 19 |
| Income before taxes | (3) | (38) | (381) | 45 | (102) | (30) | (6) |
| Income tax expense | (1) | (9) | (2) | 1 | (2) | (0) | 4 |
| Net income from continuing operations | (2) | (29) | (379) | 44 | (100) | (29) | (10) |
| Net income | (2) | (29) | (379) | 44 | (100) | (29) | (10) |
| Net income to common shareholders | – | (29) | (379) | 44 | (100) | (29) | (10) |